Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:41 PM
Ignite Modification Date:
2025-12-24 @ 10:41 PM
NCT ID:
NCT02980835
Eligibility Criteria:
Inclusion Criteria:
Patients will be eligible to enroll in this study if they:
* Have physical status within ASA class II or III
* Are between 18 and 85 years of age
* Are candidates for VATS
* Are able to complete VAS assessments
* Are competent to sign the informed consent form
Exclusion Criteria:
Patients will not be enrolled in this study if they:
* Are pregnant
* Have allergy to ropivacaine or hydromorphone
* Have renal insufficiency (eGFR\<60mL/min/1.73m2)
* Have hepatic insufficiency (AST, ALT, or both \>60 U/L) or cirrhosis
* Have a predicted postoperative forced vital capacity (FVC) of \<40%, predicted forced expiratory volume at 1s (FEV1) \<40%
* Have coagulopathy (platelet count\<50000, INR\>2, or both)
* Have a history of opioid addiction, chronically taking opioids, currently taking high dose of opioids or currently taking opioid agonist+antagonist (e.g. Suboxone®)
* Are taking nonsteroidal anti-inflammatory drug, including aspirin, within a week prior to surgery (since the analgesic effects of NSAID drugs may become confounding factors).
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
85 Years
Study:
NCT02980835
Study Brief:
Protocol Section:
NCT02980835